Zobrazeno 1 - 10
of 2 500
pro vyhledávání: '"interleukin 23"'
Autor:
Jean Massaad, Michèle Magremanne
Publikováno v:
Heliyon, Vol 10, Iss 20, Pp e38566- (2024)
MRONJ is a well-known side effect of antiresorptive and antiangiogenic drug treatment. Crohn's disease involves pro-inflammatory interleukins IL-12 and IL-23. Ustekinumab is a targeted therapy antagonist of the p40 subunit of IL-12 and -23 indicated
Externí odkaz:
https://doaj.org/article/58af45ed1a2a4cd1abc00c80e4d2983b
Autor:
Shawn G. Kwatra, Saakshi Khattri, Ahmad Z. Amin, Roberto Ranza, Blair Kaplan, Linyu Shi, Byron Padilla, Ahmed M. Soliman, Dennis McGonagle
Publikováno v:
Dermatology and Therapy, Vol 14, Iss 6, Pp 1517-1530 (2024)
Abstract Introduction The presence (vs absence) of enthesitis/dactylitis is associated with greater psoriatic arthritis (PsA) activity and reduced health-related quality of life. Risankizumab, an interleukin 23 antagonist, demonstrated superior treat
Externí odkaz:
https://doaj.org/article/208376fab02442ef8617f079f73a4f2b
Autor:
Laurent Peyrin-Biroulet, Jean-Frederic Colombel, Edouard Louis, Marc Ferrante, Satoshi Motoya, Remo Panaccione, Joana Torres, Ryan C. Ungaro, Kristina Kligys, Jasmina Kalabic, Javier Zambrano, Yafei Zhang, Geert D'Haens
Publikováno v:
Gastro Hep Advances, Vol 3, Iss 4, Pp 539-550 (2024)
Background and Aims: Early biologic therapy treatment has demonstrated better outcomes in Crohn’s disease (CD). We evaluated the impact of CD duration in patients with moderately to severely active CD treated with risankizumab therapy. Methods: Thi
Externí odkaz:
https://doaj.org/article/fa55166e9c4e42f79099e540030db28a
Publikováno v:
Kaohsiung Journal of Medical Sciences, Vol 39, Iss 8, Pp 789-800 (2023)
Abstract The interleukin‐23 (IL‐23)/IL‐17 immune axis has been linked to the pathology of psoriasis, but how this axis contributes to skin inflammation in this disease remains unclear. We measured inflammatory cytokines associated with the IL
Externí odkaz:
https://doaj.org/article/1008085a5d0545509eb2e3e021e48343
Autor:
Alexa B. Kimball, Errol P. Prens, Thierry Passeron, Emanual Maverakis, Irina Turchin, Stefan Beeck, Leonidas Drogaris, Ziqian Geng, Tianyu Zhan, Izabella Messina, Falk G. Bechara
Publikováno v:
Dermatology and Therapy, Vol 13, Iss 5, Pp 1099-1111 (2023)
Abstract Introduction Hidradenitis suppurativa (HS) is a chronic, immune-mediated skin condition characterized by inflammatory lesions that can cause pain, impaired physical activity, and reduced quality of life. This study evaluated the efficacy and
Externí odkaz:
https://doaj.org/article/e2a729e34e50461897894ec721f0c23a
Autor:
Rasmus Goll, Øystein K. Moe, Kay-Martin Johnsen, Renate Meyer, Joachim Friestad, Mona D. Gundersen, Hege Kileng, Knut Johnsen, Jon R. Florholmen
Publikováno v:
BMC Gastroenterology, Vol 22, Iss 1, Pp 1-9 (2022)
Abstract Background and aims Biological therapy for inflammatory bowel disease is efficient in many cases but not all. The underlying molecular mechanisms behind non-response to biological therapy in inflammatory bowel disease are poorly described. T
Externí odkaz:
https://doaj.org/article/24585aa8af0c4f278536725289b66640
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 156, Iss , Pp 113785- (2022)
Vitiligo is a depigmentation skin disease often coexisting with other autoimmune disorders. The prevalence is 0.5–2 % of the world's population. A combination of genetic, environmental and biochemical factors play a role in pathogenesis of the dise
Externí odkaz:
https://doaj.org/article/8b08adc8079b41c5b69e68bc23c23037
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.